Effective prophylaxis with daily recombinant factor VIIa (rFVIIa-Novoseven) in a child with high titre inhibitors and a target joint.

Suppr

超能文献

作者信息

Saxon B R, Shanks D, Jory C B, Williams V

出版信息

Thromb Haemost. 2001 Oct;86(4):1126-7.

PMID:11686341

Abstract

摘要

相似文献

Effective prophylaxis with daily recombinant factor VIIa (rFVIIa-Novoseven) in a child with high titre inhibitors and a target joint.

Thromb Haemost. 2001 Oct;86(4):1126-7.

Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.使用重组凝血因子VIIa（诺其）对有抑制物的血友病患者轻至中度出血发作进行家庭治疗。

Thromb Haemost. 1998 Dec;80(6):912-8.

Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.持续输注重组凝血因子VIIa治疗VIII因子抑制物患者时，凝血因子VII活性与临床疗效的关系

Thromb Haemost. 2001 Oct;86(4):954-8.

Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.两剂重组活化凝血因子VII（诺其）用于有抑制物的血友病患者手术的前瞻性随机试验

Thromb Haemost. 1998 Nov;80(5):773-8.

Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.重组凝血因子VIIa用于治疗VIII因子、IX因子抑制剂或VII因子缺乏的患者。

Haemophilia. 1999 Jul;5(4):253-9. doi: 10.1046/j.1365-2516.1999.00319.x.

Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations.10例重度甲型血友病伴抑制物患者的预防治疗：针对不同临床情况的不同方法。

Haemophilia. 2009 Jan;15(1):203-9. doi: 10.1111/j.1365-2516.2008.01915.x.

[Successful treatment of hemothorax with recombinant factor VIIa in a hemophilic child with inhibitor].[重组因子VIIa成功治疗一名患有抑制剂的血友病儿童的血胸]

Vnitr Lek. 1998 Sep;44(9):547-50.

Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial.血友病及存在抑制剂患者使用单剂量重组活化因子VII进行关节积血的家庭治疗。一项多中心、随机、双盲、交叉试验。

Thromb Haemost. 2006 Apr;95(4):600-5.

Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor.成本与结果：对血友病A合并抑制剂患者的两种替代旁路制剂的比较

Thromb Haemost. 2008 Jun;99(6):1060-7. doi: 10.1160/TH07-11-0698.

Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.重组凝血因子VIIa用于一名患有严重血友病A且有凝血因子VIII抑制物的耶和华见证会信徒的颅内出血治疗。

Blood Coagul Fibrinolysis. 1993 Dec;4(6):1031-3.

引用本文的文献

Increased Accumulation and Retention of rhFVIIa (eptacog beta) in Knee Joints of Hemophilia A Mice Compared to Wild-Type Mice.与野生型小鼠相比，血友病 A 小鼠膝关节中 rhFVIIa（eptacog beta）的蓄积和滞留增加。

Thromb Haemost. 2019 Aug;119(8):1283-1294. doi: 10.1055/s-0039-1688907. Epub 2019 May 26.

Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.内皮细胞蛋白 C 受体介导的因子 VIIa 重分布和组织水平蓄积。

J Thromb Haemost. 2012 Nov;10(11):2383-91. doi: 10.1111/j.1538-7836.2012.04917.x.

The expanding role of prophylaxis with recombinant activated factor VII.重组活化凝血因子 VII 在预防治疗中的作用不断扩大。

Blood Transfus. 2013 Jan;11(1):12-3. doi: 10.2450/2012.0061-12. Epub 2012 Jul 4.

Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors.重组活化凝血因子VII在治疗伴有凝血因子抑制物的血友病患者中作用的批判性评价

J Blood Med. 2010;1:37-48. doi: 10.2147/JBM.S6209. Epub 2010 Mar 30.

Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy.复发性流产与抗磷脂抗体：对后续妊娠的预后影响。

J Thromb Haemost. 2010 Oct;8(10):2208-13. doi: 10.1111/j.1538-7836.2010.04015.x.

rFVIIa transported from the blood stream into tissues is functionally active.从血流转运至组织中的重组活化凝血因子VII（rFVIIa）具有功能活性。

J Thromb Haemost. 2010 Oct;8(10):2318-21. doi: 10.1111/j.1538-7836.2010.04010.x.

Animal models of FVIIa gene expression: their role in the future development of haemophilia treatment.动物模型中的 FVIIa 基因表达：在未来血友病治疗中的作用。

Haemophilia. 2010 Mar;16 Suppl 2(0 2):24-7. doi: 10.1111/j.1365-2516.2009.02199.x.

Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa).药物管理的重组因子 VIIa（rFVIIa）的生物分布。

J Thromb Haemost. 2010 Feb;8(2):301-10. doi: 10.1111/j.1538-7836.2009.03696.x. Epub 2009 Nov 23.

Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors.八因子抑制剂旁路活性（FEIBA）在高滴度抑制剂血友病患者出血管理中的应用

Vasc Health Risk Manag. 2007;3(4):527-31.

Postoperative pulmonary thromboembolism possibly associated with recombinant activated factor VII infusion for the treatment of uncontrolled hemorrhage during vertebral instrumentation.术后肺血栓栓塞可能与重组活化凝血因子VII输注治疗椎体器械固定术中难以控制的出血有关。

J Anesth. 2007;21(2):258-60. doi: 10.1007/s00540-006-0481-y. Epub 2007 May 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验